We are excited to announce that the CINP 2026 Congress in Glasgow will be held as a Joint Meeting with the Scandinavian College of Neuropsychopharmacology (SCNP).

As part of this event, SCNP will host a dedicated one-day meeting on Friday, 26th June, open to all joint meeting delegates. The main CINP Congress programme will also feature:

• A Scandinavian Plenary Lecture
• Several SCNP-led symposia, and
• An SCNP Early Career Symposium, highlighting the work of emerging Scandinavian researchers selected through open competition.

Follow the CINP2026 website and our social media, or  subscribe to our newsletter for all news and updates. 

Subscribe Here

We are delighted to announce the recipients of the CINP Pioneer Award 2026

• Prof. Barbara J. Sahakian (UK)
  
  
• Prof. Pierre Blier (Canada) 

The Pioneer Award is given at each World Congress of Neuropsychopharmacology to honour those who have made major contributions to the growth of the field.

The awards will be presented during the Opening ceremony of the CINP2026 Congress in Glasgow on June 26, 2026.

For more information about the award and the the recipients' bios

Read Here

Congratulations to both awardees! 

The symposia submission for CINP2026 in Glasgow is open!

We welcome proposals for symposia of 75 min duration that integrate the latest advances in basic, clinical, and translational neuropsychopharmacology, as well as biological psychiatry, drug development, public policy issues relevant to mental health, mental illness, and treatment across the lifespan.

A total of 30 symposia will be selected, of which 12 will be eligible for financial coverage of USD 5,000. 

Speakers in the remaining 18 selected symposia will receive complimentary congress registration plus complimentary registration to the networking dinner.

Find All Details Here